Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.87 AUD | +1.16% | -2.25% | +20.00% |
Apr. 23 | SDI Obtains European Union's Medical Device Regulation Certification; Shares Up 3% | MT |
Feb. 28 | SDI Posts Higher Profit, Revenue in H1 FY24 | MT |
Valuation
Fiscal Period: June | 2020 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 83.8 | 98.06 | 103.4 | - | - |
Enterprise Value (EV) 1 | 83.8 | 116.2 | 122.4 | 139.4 | 152.4 |
P/E ratio | 19.8 x | 13.9 x | 10.7 x | 10 x | 10.7 x |
Yield | - | 3.94% | 3.22% | 3.56% | 3.22% |
Capitalization / Revenue | - | 0.91 x | 0.89 x | 0.81 x | 0.75 x |
EV / Revenue | - | 1.08 x | 1.06 x | 1.09 x | 1.1 x |
EV / EBITDA | - | 7.17 x | 6.12 x | 6.64 x | 6.63 x |
EV / FCF | - | - | 61.2 x | -10.7 x | -13.9 x |
FCF Yield | - | - | 1.63% | -9.32% | -7.22% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 118,866 | 118,866 | 118,866 | - | - |
Reference price 2 | 0.7050 | 0.8250 | 0.8700 | 0.8700 | 0.8700 |
Announcement Date | 8/20/20 | 8/23/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2020 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | - | 107.9 | 116 | 128 | 138 |
EBITDA 1 | - | 16.2 | 20 | 21 | 23 |
EBIT 1 | - | 11.89 | 15 | 16 | 17 |
Operating Margin | - | 11.02% | 12.93% | 12.5% | 12.32% |
Earnings before Tax (EBT) | - | - | - | - | - |
Net income 1 | 4.237 | 7.1 | 10 | 10 | 10 |
Net margin | - | 6.58% | 8.62% | 7.81% | 7.25% |
EPS 2 | 0.0356 | 0.0594 | 0.0810 | 0.0870 | 0.0810 |
Free Cash Flow 1 | - | - | 2 | -13 | -11 |
FCF margin | - | - | 1.72% | -10.16% | -7.97% |
FCF Conversion (EBITDA) | - | - | 10% | - | - |
FCF Conversion (Net income) | - | - | 20% | - | - |
Dividend per Share 2 | - | 0.0325 | 0.0280 | 0.0310 | 0.0280 |
Announcement Date | 8/20/20 | 8/23/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: |
---|
Balance Sheet Analysis
Fiscal Period: June | 2020 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | - | 18.1 | 19 | 36 | 49 |
Net Cash position 1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 1.117 x | 0.95 x | 1.714 x | 2.13 x |
Free Cash Flow 1 | - | - | 2 | -13 | -11 |
ROE (net income / shareholders' equity) | - | 8.27% | 10% | 10% | 9% |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | - | 5 | 20 | 20 |
Capex / Sales | - | - | 4.31% | 15.62% | 14.49% |
Announcement Date | 8/20/20 | 8/23/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.00% | 68.39M | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.8B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- SDI Stock
- Financials SDI Limited